drugset / Trial / NCT00862108
Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
Phase 4
Unknown
50 enrolled
Seoul National University Hospital
Korea Health Industry Development Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD
Timeline
- Start
- 2008-09
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 0.7 mg/kg | Oral |
| Subject | Methylphenidate | Small molecule | 1.2 mg/kg | Oral |